Antibody-drug conjugate targeting folate receptor α: A new milestone in personalized medicine for high-grade serous ovarian cancer
Revue:
International Journal of Gynecological Cancer
ISSN: 1525-1438, 1048-891X
Année de publication: 2024
Type: Éditorial